EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lupus Nephritis Biomarkers: A Critical Review

Fatima K Alduraibi iD, George C Tsokos iD

International Journal of Molecular Sciences · 09.01.2024 · 25 (2) · 805

DOI: 10.3390/ijms25020805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.01.2024. Verfasst von Fatima K Alduraibi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Clinical Immunology and Rheumatology, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, MA…. Hauptthemen laut MEDLINE: Lupus Nephritis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN), a major complication in individuals diagnosed with systemic lupus erythematosus, substantially increases morbidity and mortality. Despite marked improvements in the survival of patients with severe LN over the past 50 years, complete clinical remission after immunosuppressive therapy is achieved in only half of the patients. Therefore, timely detection of LN is vital for initiating prompt therapeutic interventions and improving patient outcomes. Biomarkers have emerged as valuable tools for LN detection and monitoring; however, the complex role of these biomarkers in LN pathogenesis remains unclear. Renal biopsy remains the gold standard for the identification of the histological phenotypes of LN and guides disease management. However, the molecular pathophysiology of specific renal lesions remains poorly understood. In this review, we provide a critical, up-to-date overview of the latest developments in the field of LN biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisLupus Erythematosus, SystemicHumansBiomarkersKidneyPhenotypePathologic Complete Response

Stichwörter der Autor:innen

biomarkerlupus nephritissystemic lupus erythematosus

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Medicine, Division of Clinical Immunology and Rheumatology, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, MA 02215, USA.
  • Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Medicine, Division of Clinical Immunology and Rheumatology, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.

ORCID-Profile: Fatima K Alduraibi, George C Tsokos

Zitieren

APA

Alduraibi, F. K., & Tsokos, G. C. (2024). Lupus Nephritis Biomarkers: A Critical Review. International Journal of Molecular Sciences, 25(2), 805. https://doi.org/10.3390/ijms25020805

Vancouver

Alduraibi FK, Tsokos GC. Lupus Nephritis Biomarkers: A Critical Review. International Journal of Molecular Sciences. 2024;25(2):805. doi:10.3390/ijms25020805

BibTeX
@article{Alduraibi2024,
  author = {Alduraibi, Fatima K and Tsokos, George C},
  title = {Lupus Nephritis Biomarkers: A Critical Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {805},
  doi = {10.3390/ijms25020805}
}
Kostenlos starten →